Day 1

Chronic Total Occlusions

solaci
solaci
470
0

13_guzman_luis

Luis A Guzman
2014-08-07

Director, Cardiovascular Interventions
University of Florida-Jacksonville

Previous article
Hemoducto Venoso: Cambio en el Paradigma de Tratamiento
Next article
Caso Clinico
solaci
solaci

More articles by this author

Nuevas Estrategias de Reperfusión Miocárdica en el IAM con Elevación del Segmento ST

solaci - 0
José Mangione2014-08-07

Prevención y Manejo de dificultades en la via radial

solaci - 0
Pablo Vázquez Grenno 2014-08-07Sanatorio Americano. CCAMontevideo. Uruguay

Caso Clinico

solaci - 0
Alfaro Marchena Noriega2014-08-07Vicepresidente Sociedad Panameña de CardiologíaPresidente Fundación Cardiológica de Panamá

Hemoducto Venoso: Cambio en el Paradigma de Tratamiento

solaci - 0
Augusto Pichard2014-08-07Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of Medicine (Cardiology),Georgetown University Medical School.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 0
The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Dr. Juan Manuel Pérez - 0
Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...